Effect of down-regulation of histone deacetylase 2 protein expression on cell proliferation and cell cycle in cervical carcinoma

Chinese Journal of Pathology

Volumn 41, Issue 7, 2012, Pages 466-469

  Hua, Fang Fang ^a   Xia, Yong Hua ^a   Wu, Da Peng ^a   Chen, Rui Xiang ^a   Wang, Yu Hong ^a   Pan, Ying ^a   Yang, Jun ^a   Liang, Wu Feng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Cell line, tumor; Cell proliferation; Cyclins; Histone deacetylase 2; Uterine cervical neoplasms

Indexed keywords

CCND1 PROTEIN, HUMAN; CCNE1 PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; HDAC2 PROTEIN, HUMAN; HISTONE DEACETYLASE 2; ONCOPROTEIN; PROTEIN P21; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; DOWN REGULATION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METABOLISM;

CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; DOWN-REGULATION; HELA CELLS; HISTONE DEACETYLASE 2; HUMANS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84864678857     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2012.07.008     Document Type: Article

References (14)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2) : 69-90.
2. Pectasides D, Kamposioras K, Papaxoinis G, et al. Chemotherapy for recurrent cervical cancer. Cancer Treat Rev, 2008, 34 (7) : 603-613.
3. Yang XJ, Seto E. The Rpd3/Hdal family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol, 2008, 9(3):206-218.
4. Spange S, Wagner T, Heinzel T, et al. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol, 2009, 41(1): 185-198.
5. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet, 2009, 10 (1) : 32-42.
6. Bieliauskas AV, Pflum MK. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev, 2008, 37(7) : 1402-1413.
7. Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett, 2009, 280(2) : 168-176. [8]
8. Chang HH, Chiang CP, Hung HC, et al. Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol, 2009, 45(7): 610-614.
9. Chang CC, Lin BR, Chen ST, et al. HDAC2 promotes cell migration/invasion abilities through HIF-I a stabilization in human oral squamous cell carcinoma. J Oral Pathol Med, 2011, 40(7) : 567-575.
10. Fritzsche FR, Weichert W, Rdske A, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer, 2008, 8 : 381.
11. Borowiec AS, Hague F, Gouilleux-Gruart V, et al. Regulation of IGF-I-dependent cyclin D1 and E expression by hEagl channels in MCF-7 cells: the critical role of hEagl channels in G1 phase progression. Biochim Biophys Acta, 2011, 1813(5) : 723-730.
12. Masamha CP, Benbrook DM. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res, 2009, 69 (16) : 6565-6572.
13. Smartt HJ, Guilmeau S, Nasser SV, et al. P-27kipl regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia. Gastroenterology, 2007, 133(1): 232-243. (Pubitemid 47031132)
14. Chen CY, Hsu YL, Chen YY, et al. Isokotomolide A, a new butanolide extracted from the leaves of Cinnamomum kotoense, arrests cell cycle progression and induces apoptosis through the induction of p53/p21 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells. Eur J Pharmacol, 2007, 574(2-3) : 94-102.